Esempio: Heart Attack

Cerca studi clinici per: Alefacept

Totale 39 risultati

NCT01226420

Terminato

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Condizioni: Chronic Graft-versus-host Disease
NCT01319851

Terminato

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Condizioni: Thalassemia; Sickle Cell Disease; Glanzmann Thrombasthenia; Wiskott-Aldrich Syndrome; Chronic-granulomatous Disease; Severe Congenital Neutropenia; Leukocyte Adhesion Deficiency; Schwachman-Diamond Syndrome; Diamond-Blackfan Anemia; Fanconi Anemia; Dyskeratosis-congenita; Chediak-Higashi Syndrome; Severe Aplastic Anemia
NCT00832585

Completato

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Condizioni: Atopic Dermatitis
NCT00953329

Terminato

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy

Condizioni: Chronic Plaque Psoriasis
NCT00655564

Completato

Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

Condizioni: Psoriasis
NCT01433770

Ritirato

Alefacept in Kidney Transplant Recipients

Condizioni: Kidney Transplantation
NCT00965458

Terminato

Inducing Remission in Type 1 Diabetes With Alefacept

Condizioni: New-onset Type 1 Diabetes Mellitus
NCT00815633

Terminato

A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris

Condizioni: Pityriasis Rubra Pilaris
NCT00808223

Completato

Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis

Condizioni: Psoriasis
NCT00454701

Terminato

Assessment and Tracking of Long-term Alefacept Safety

Condizioni: Psoriasis
NCT00361413

Terminato

Alefacept for Prevention of Graft Versus Host Disease (GVHD)

Condizioni: Graft Versus Host Disease
NCT00438802

Completato

Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma

Condizioni: Lymphoma
NCT00658606

Completato

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Condizioni: Plaque Psoriasis
NCT01163799

Terminato

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Condizioni: Transplant; Failure, Kidney
NCT00794807

Completato

Safety and Tolerability of Repeat Courses of IM Alefacept

Condizioni: Chronic Plaque Psoriasis
NCT00795353

Terminato

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Condizioni: Chronic Plaque Psoriasis
NCT01267643

Terminato

Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

Condizioni: Aplastic Anemia
NCT00678470

Completato

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Condizioni: Moderate to Severe Psoriasis
NCT00674063

Completato

A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis

Condizioni: Chronic Plaque Psoriasis
NCT00692172

Completato

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Condizioni: Psoriasis
NCT00342862

Terminato

AMEVIVE® Pregnancy Registry

Condizioni: Pregnancy
NCT00167102

Completato

Alefacept in Patients With Severe Scalp Alopecia Areata

Condizioni: Alopecia Areata
NCT00168753

Completato

Community Based Trial for AMEVIVE®

Condizioni: Moderate to Severe Chronic Plaque Psoriasis
NCT00673556

Completato

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

Condizioni: Chronic Plaque Psoriasis
NCT00397332

Completato

Alefacept for Chronic Graft Versus Host Disease

Condizioni: Resistant Chronic GVHD